Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.82%
#3 Ankr Network Ankr Network +20.98%
#4 BankrCoin BankrCoin +19.15%
#5 Status Status +12.73%
#6 Hive Hive +11.15%
#7 Pons Pons +9.35%
#8 Provenance Blockchain Provenance Blockchain +9.19%
#9 Prom Prom +8.82%
#10 Useless Coin Useless Coin +8.39%
Coin of the day
Palladium Network Palladium Network
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

VYGR
Classement en actions #18069
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating... Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Prix de l'action
$3.54
Dernière synchronisation: 2026-09-02
Capitalisation boursière
$213.59M
Changement (1 jour)
3.06%
Changement (1 an)
-3.94%
Pays
US
Échange Voyager Therapeutics, Inc. (VYGR)

Catégorie

Healthcare
Historique des dividendes pour Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics, Inc. (symbole boursier : VYGR) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Voyager Therapeutics, Inc. (VYGR) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH